Treadwell Therapeutics

Plus: Updates from Cardiff, Regenics, X-chem

Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more

Plus: Santhera promotes van Daal and Schrader, and updates from Treadwell, LIB, Rentschler and Avalere

Data reported in SITC abstracts show single-digit percentage responses

With GV joining investor syndicate, the biotech’s ‘non-linear’ path will include HPK1 program rivaling Pfizer’s, as well as immunology and metabolic assets

Plus: Myers at the helm of Viridian, and updates from Novartis, 

Building international business through overseas subsidiary, Chinese company buys U.K. biotech with tetravalent bispecifics, STING agonist 

Plus: SIB’s Durinx joins VIB, and updates from Orion, American Cancer Society, Ambys and more

Sanofi invests in Owkin, plus Treadwell, Protego, BAKX, Fountain, Takeda-Denali